A new study has found that coenzyme Q10 (CoQ10) reduces inflammatory markers and improves the survival of patients with sepsis. A life-threatening condition responsible for the deaths of up to 8 million people globally each year, sepsis occurs when an infection gets out of control and triggers an overwhelming immune response. With sepsis being a common cause of death in coronavirus patients, the finding adds further support to the potential for natural health approaches to help save lives in the current pandemic.
Published by researchers in Iran, the study was conducted in the form of a randomized controlled trial that investigated the effectiveness of CoQ10 when given in addition to standard sepsis treatment. Involving a total of 40 patients split across two equal groups, one group received 100 mg of CoQ10 twice a day for seven days while the other functioned as the control group. The study results showed that patients given CoQ10 had a significantly lower risk of death. A total of 13 patients (65 percent) from the control group died, compared to only 4 (20 percent) of those receiving CoQ10.
The patients who were given CoQ10 also had reduced inflammatory markers. Associated not only with infections but also injuries and diseases such as cardiovascular disease and cancer, the inflammatory response has the potential to damage the body because it involves the breakdown of tissue. Previous research conducted by scientists at the Dr. Rath Research Institute has shown that a specific combination of micronutrients is particularly beneficial in inflammation and superior to pharmaceutical drugs in controlling its key mechanisms.
The Iranian researchers note in their study that several previous studies have demonstrated that CoQ10 levels are low in sepsis patients. This finding is consistent with Dr. Rath’s Cellular Medicine concept, which explains that micronutrient deficiency is the primary cause of today’s most common diseases.
Other researchers have further confirmed the link between sepsis and micronutrient deficiency. In a scientific paper published in 2018, Dr. Paul E. Marik, an intensive-care unit physician at the Eastern Virginia Medical School in the United States, described how 40 percent of patients with septic shock, the severe form of sepsis, have extremely low levels of vitamin C that are consistent with a diagnosis of scurvy. Reiterating what Dr. Rath has been pointing out for three decades now, Marik’s paper states that humans are among the very few mammals that are unable to synthesize their own vitamin C in their livers. Mirroring the micronutrient synergy approach pioneered by scientists at the Dr. Rath Research Institute, Marik has had impressive results treating sepsis patients with an intravenous combination of vitamin C, vitamin B1, and the hormone hydrocortisone.
Additional research has found a significant association between vitamin D deficiency and the risk of sepsis. Vitamin D deficiency is known to increase the risk of death in critically ill patients with the condition. Research further shows that critically ill children with sepsis have a high prevalence of vitamin A deficiency.
With researchers from China recently finding that fish oil can significantly reduce mortality risk and decrease the time critically ill sepsis patients stay in hospital intensive care units, scientific evidence is accumulating that natural health approaches can play an important role in reducing the global death toll from this life-threatening condition.